# THC and CBD Induce Cell Death via Heme Oxygenase-1 in Skin Cancer Cells > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabinoids-skin-cancer-research-thc-cbd-effects/ > **Published:** 2026-03-28T08:16:52-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:36:20-04:00 > **Clinical Summary:** Explore cannabinoids skin cancer research showing how THC and CBD induce cell death and mitochondrial dysfunction in melanoma and squamous carcinoma cells. --- CED Clinical Relevance  #66Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic OncologyThcCbdDermatologyPreclinical Journal Antioxidants (Basel, Switzerland) Study Type [Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) Population Human participants Why This Matters This preclinical study provides mechanistic insight into how cannabinoids may exert anticancer effects specifically in melanoma and squamous cell carcinoma. Understanding these cellular pathways could inform future clinical applications of cannabinoids in dermatologic oncology. Clinical Summary This laboratory study examined THC and CBD effects on human melanoma and cutaneous squamous cell carcinoma cell lines. Researchers found both cannabinoids induced cell death through heme oxygenase-1 dependent pathways and caused mitochondrial dysfunction in cancer cells. The study utilized in vitro cell culture models to examine cellular mechanisms rather than testing therapeutic efficacy in patients. While the molecular findings are interesting, this represents early-stage preclinical research without direct clinical translation. Dr. Caplan’s Take “This is promising laboratory work, but we’re still years away from knowing whether cannabinoids could be clinically useful for skin cancer treatment. The mechanistic data is intriguing, but cellular studies don’t predict human therapeutic outcomes.” Clinical Perspective 🧠 Patients should not interpret this as evidence that cannabis treats skin cancer – this was laboratory research on isolated cells, not human treatment studies. Clinicians should continue following established skin cancer treatment protocols while monitoring the evolution of [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) in oncology. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20THC%20and%20CBD%20Induce%20Heme%20Oxygenase-1-Dependent%20Cell%20Death%20and%20Trigger%20Mitochondri...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41897433/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41897433/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20THC%20and%20CBD%20Induce%20Heme%20Oxygenase-1-Dependent%20Cell%20Death%20and%20Trigger%20Mitochondri...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41897433/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41897433/](https://pubmed.ncbi.nlm.nih.gov/41897433/) Table of Contents - [FAQ](#FAQ)[Can THC and CBD be used to treat skin cancer in patients?](#Can_THC_and_CBD_be_used_to_treat_skin_cancer_in_patients) - [What mechanism allows cannabinoids to kill skin cancer cells?](#What_mechanism_allows_cannabinoids_to_kill_skin_cancer_cells) - [Are there safety concerns with using cannabinoids for cancer treatment?](#Are_there_safety_concerns_with_using_cannabinoids_for_cancer_treatment) - [How do these findings compare to current skin cancer treatments?](#How_do_these_findings_compare_to_current_skin_cancer_treatments) - [What are the next steps needed before clinical application?](#What_are_the_next_steps_needed_before_clinical_application) - [Related](#Related) ## FAQ #### Can THC and CBD be used to treat skin cancer in patients? This is preclinical research conducted only in laboratory cell cultures, not in human patients. While the study shows promising anti-cancer effects against melanoma and squamous cell carcinoma cells, extensive [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) are needed before cannabinoids could be considered as skin cancer treatments. #### What mechanism allows cannabinoids to kill skin cancer cells? The study found that THC and CBD induce cell death through activation of heme oxygenase-1 (HO-1) and disruption of mitochondrial function. This represents a specific pathway that leads to programmed cell death in cancer cells, though the exact clinical implications remain unclear. #### Are there safety concerns with using cannabinoids for cancer treatment? The study focused only on cancer cell effects and did not evaluate safety in normal skin cells or potential systemic effects. Clinical safety data would be essential before any therapeutic application, particularly regarding effects on healthy tissue and drug interactions. #### How do these findings compare to current skin cancer treatments? This preclinical study cannot be directly compared to established treatments like surgery, radiation, or immunotherapy. The research represents early-stage investigation into potential new mechanisms, but proven clinical efficacy and safety profiles of current treatments remain the standard of care. #### What are the next steps needed before clinical application? Extensive preclinical studies in animal models are needed, followed by Phase I [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) to establish safety and dosing. The research must also determine optimal [delivery methods](https://cedclinic.com/state-ban-smokable-cannabis-impact-central-texas/), bioavailability, and potential combination with existing therapies before any clinical consideration. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “THC and CBD Induce Heme Oxygenase-1-Dependent Cell Death and Trigger Mitochondrial Dysfunction in Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41897433/”, “about”: “antioxidants basel switzerland [clinical study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) thc”, “isPartOf”: “Antioxidants (Basel, Switzerland)”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Newly discovered mysterious cell helps in birth, but dies soon after; suggests that cannabis …](https://cedclinic.com/newly-discovered-mysterious-cell-helps-in-birth-but-dies-soon-after-suggests-that-cannabis/) Explore recent discoveries on how cannabis-related cells impact biological processes, offering insights relevant to [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/). [Read More](https://cedclinic.com/newly-discovered-mysterious-cell-helps-in-birth-but-dies-soon-after-suggests-that-cannabis/) [Study Finds Cannabis Compounds May Help Reduce Fatty Liver Disease](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) Learn about emerging research on [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) and their potential therapeutic effects beyond oncology. [Discover More](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) [CBD may calm the brain's runaway immune response behind Alzheimer's – MSN](https://cedclinic.com/project-cbd-newsletter-cbd-for-neuroinflammation-alzheimers-neuropathic-pain-oral/) Understand how CBD's anti-inflammatory properties might influence neurodegenerative diseases, complementing oncology research. [Explore Article](https://cedclinic.com/project-cbd-newsletter-cbd-for-neuroinflammation-alzheimers-neuropathic-pain-oral/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).